Use windshield time to sharpen your real estate business
Testing the discount Premier David Eby has defended the plan as opportunistic buying in a weak market. “Ultimately we’ll be buying below the cost of construction. No developers will be profiting from this,” Eby said. He said the program would not work for units in the City of Vancouver, where prices remain too high, but…
Under Warren Buffett’s leadership and now continuing with Greg Abel at the helm, Berkshire Hathaway has long sought out exceptional businesses capable of compounding value over decades rather than chasing short-term market movements. In years past, Buffett described certain portfolio investments as forever stocks — stakes in companies that are so fundamentally strong that Berkshire…
CIRO’s president and CEO, Andrew Kriegler, welcomed the organization’s expanded role overseeing mutual fund representatives in the province. “We are honoured to expand our involvement in the regulatory oversight of mutual fund representatives in Québec. With today’s announcement, we have created greater regulatory clarity and a single point-of-contact for mutual fund dealers and their representatives,…
Government of Alberta data cited by Lurie shows a modest net provincial population increase of roughly 5,000 people between October and January, a marked deceleration from earlier boom-era growth, with international migration contracting. Statistics Canada’s Q4 2025 demographic estimates corroborate the trend, placing Alberta’s net interprovincial gain at 3,684 people in that quarter, down from 4,993…
Chip stocks led a Monday rally that lifted two of the three major indexes while leaving the third stuck near the flatline. The Nasdaq Composite (^IXIC +1.20%) gained 1.3% by 12:48 p.m. ET. The S&P 500 (^GSPC +0.79%) rose 0.7% at the same time. The Dow Jones Industrial Average (^DJI +0.12%) slipped 0.1% after briefly…
Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNR) give investors a way to access this growing market. What was once a small corner of the pharmaceutical market is now expected to become a $130 billion to $150 billion market…